First Trust Advisors
TNDM icon

First Trust Advisors’s Tandem Diabetes Care TNDM Stock Holding History

First Trust Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.42M Sell
292,844
-49,863
-15% -$871K ﹤0.01% 1657
2026
Q1 		$6.57M Buy
+342,707
New +$7.45M ﹤0.01% 1302
2025
Q4 		– Sell
-40,730
Closed -$494K – 2714
2025
Q3 		$494K Buy
+40,730
New +$551K ﹤0.01% 2314
2025
Q2 		– Sell
-39,876
Closed -$764K – 2708
2025
Q1 		$764K Sell
39,876
-38,025
-49% -$1.11M ﹤0.01% 2127
2024
Q4 		$2.81M Sell
77,901
-21,204
-21% -$717K ﹤0.01% 1665
2024
Q3 		$4.2M Sell
99,105
-279,792
-74% -$11.9M ﹤0.01% 1418
2024
Q2 		$15.3M Buy
378,897
+36,027
+11% +$1.5M 0.02% 877
2024
Q1 		$12.1M Buy
+342,870
New +$9.19M 0.01% 962
2022
Q3 		– Sell
-133,481
Closed -$7.9M – 2605
2022
Q2 		$7.9M Sell
133,481
-119,392
-47% -$9.8M 0.01% 1036
2022
Q1 		$29.4M Buy
252,873
+52,798
+26% +$6.16M 0.03% 659
2021
Q4 		$30.1M Buy
200,075
+175,623
+718% +$23.7M 0.03% 670
2021
Q3 		$2.92M Buy
+24,452
New +$2.69M ﹤0.01% 1610
2021
Q2 		– Sell
-13,950
Closed -$1.23M – 2552
2021
Q1 		$1.23M Sell
13,950
-210,365
-94% -$19.6M ﹤0.01% 1918
2020
Q4 		$21.5M Sell
224,315
-67,756
-23% -$6.98M 0.03% 603
2020
Q3 		$33.1M Buy
292,071
+234,490
+407% +$24.6M 0.05% 422
2020
Q2 		$5.7M Buy
57,581
+10,902
+23% +$870K 0.01% 937
2020
Q1 		$3M Buy
46,679
+18,500
+66% +$1.3M 0.01% 1083
2019
Q4 		$1.68M Sell
28,179
-24,233
-46% -$1.49M ﹤0.01% 1649
2019
Q3 		$3.09M Buy
52,412
+8,362
+19% +$534K 0.01% 1286
2019
Q2 		$2.84M Sell
44,050
-22,407
-34% -$1.45M 0.01% 1370
2019
Q1 		$4.22M Sell
66,457
-13,517
-17% -$710K 0.01% 1115
2018
Q4 		$3.04M Buy
+79,974
New +$2.82M 0.01% 1239

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

First Trust Advisors's TNDM Position: Q2 2026 in Review

First Trust Advisors reduced its Tandem Diabetes Care (TNDM) stake by 15% in Q2 2026, selling an estimated $871K and leaving 292,844 shares worth $4.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1657.

First Trust Advisors first reported a position in TNDM in Q4 2018 and has held it in 22 quarters since. The position peaked at $33.1M in Q3 2020. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • First Trust Advisors held 292,844 shares of Tandem Diabetes Care worth $4.42M as of Q2 2026.
  • First Trust Advisors sold 49,863 Tandem Diabetes Care shares in Q2 2026, an estimated $871K.
  • Tandem Diabetes Care made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #1657 holding.
  • First Trust Advisors first reported a position in Tandem Diabetes Care in Q4 2018 and has held it in 22 quarters since.
  • First Trust Advisors's Tandem Diabetes Care position peaked at $33.1M in Q3 2020.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.